88 related articles for article (PubMed ID: 32525541)
1. Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia.
Mattis DM; Wang SA; Lu CM
Am J Clin Pathol; 2020 Aug; 154(3):305-318. PubMed ID: 32525541
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
[TBL] [Abstract][Full Text] [Related]
3. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
[TBL] [Abstract][Full Text] [Related]
4. Hypereosinophilic Syndrome with Endomyocarditis: Identification by Next-Generation Sequencing of the JAK2-V617F Mutation.
Tesfamicael R; Aung T; Domin Lee T; Brahn E
Eur J Rheumatol; 2023 Apr; 10(2):67-70. PubMed ID: 37470384
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
Nguyen L; Saha A; Kuykendall A; Zhang L
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611061
[TBL] [Abstract][Full Text] [Related]
6. Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2.
Romagnoli S; Bartalucci N; Gesullo F; Balliu M; Bonifacio S; Fernandez AGL; Mannelli F; Bolognini D; Pelo E; Mecucci C; Guglielmelli P; Vannucchi AM
Biomark Res; 2021 Nov; 9(1):83. PubMed ID: 34772467
[TBL] [Abstract][Full Text] [Related]
7. Activating
Umrau K; Naganuma K; Gao Q; Dogan A; Kizaki M; Roshal M; Liu Y; Yabe M
Leuk Lymphoma; 2023 Jan; 64(1):238-241. PubMed ID: 36308018
[No Abstract] [Full Text] [Related]
8. Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
Stella S; Massimino M; Manzella L; Pennisi MS; Tirrò E; Romano C; Vitale SR; Puma A; Tomarchio C; Gregorio SD; Palumbo GA; Vigneri P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418988
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic workup in front of an hypereosinophilia in 2020].
Bonnin A; Vignon G; Mottaz P; Labrousse J; Carrere F; Augereau PF; Aucher P; Lellouche F
Ann Biol Clin (Paris); 2020 Aug; 78(4):399-409. PubMed ID: 32540797
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
Roufosse F; Kahn JE; Rothenberg ME; Wardlaw AJ; Klion AD; Kirby SY; Gilson MJ; Bentley JH; Bradford ES; Yancey SW; Steinfeld J; Gleich GJ;
J Allergy Clin Immunol; 2020 Dec; 146(6):1397-1405. PubMed ID: 32956756
[TBL] [Abstract][Full Text] [Related]
11. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
Helbig G; Klion AD
Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology.
Fagni F; Bello F; Emmi G
Front Med (Lausanne); 2021; 8():627776. PubMed ID: 33718405
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
[TBL] [Abstract][Full Text] [Related]
15. CD3
Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
[TBL] [Abstract][Full Text] [Related]
16. Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial.
Taylor J; Mi X; Penson AV; Paffenholz SV; Alvarez K; Sigler A; Chung SS; Rampal RK; Park JH; Stein EM; Tallman MS; Sen F; Gönen M; Abdel-Wahab O; Klimek VM
Lancet Haematol; 2020 Aug; 7(8):e566-e574. PubMed ID: 32735836
[TBL] [Abstract][Full Text] [Related]
17. The multidisciplinary approach to eosinophilia.
Thomsen GN; Christoffersen MN; Lindegaard HM; Davidsen JR; Hartmeyer GN; Assing K; Mortz CG; Martin-Iguacel R; Møller MB; Kjeldsen AD; Havelund T; El Fassi D; Broesby-Olsen S; Maiborg M; Johansson SL; Andersen CL; Vestergaard H; Bjerrum OW
Front Oncol; 2023; 13():1193730. PubMed ID: 37274287
[TBL] [Abstract][Full Text] [Related]
18. Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach.
Quirce S; Cosío BG; España A; Blanco R; Mullol J; Santander C; Del Pozo V
Front Immunol; 2023; 14():1192284. PubMed ID: 37266434
[TBL] [Abstract][Full Text] [Related]
19. FIP1L1-PDGFRα-Positive Loeffler Endocarditis-A Distinct Cause of Heart Failure in a Young Male: The Role of Multimodal Diagnostic Tools.
Varga A; Moldovan DA; Pop M; Benedek I; Kövecsi A; Dumbrava RA; Iancu DG; Cristescu L; Huma L; Tilea I
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238279
[TBL] [Abstract][Full Text] [Related]
20. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Valent P; Klion AD; Roufosse F; Simon D; Metzgeroth G; Leiferman KM; Schwaab J; Butterfield JH; Sperr WR; Sotlar K; Vandenberghe P; Hoermann G; Haferlach T; Moriggl R; George TI; Akin C; Bochner BS; Gotlib J; Reiter A; Horny HP; Arock M; Simon HU; Gleich GJ
Allergy; 2023 Jan; 78(1):47-59. PubMed ID: 36207764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
